Skip to content

Clinical trials

Phase 2 Major Depressive Disorder trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 2 Country / region: Australia Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20073
20092
20102
20111
20191
20201
20212
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Unknown status2
Active, not recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The University of New South Wales6
Actinogen Medical1
Bayside Health1
Boehringer Ingelheim1
GlaxoSmithKline1
H. Lundbeck A/S1
Praxis Precision Medicines1
Shire1
The Alfred1
The University of Queensland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder17
Mood Disorders6
Depressive Disorder4
Depressive Disorder, Treatment-Resistant2
Mental Disorders2
Anxiety Disorders1
Bipolar Disorder1
Cognitive Dysfunction1
Dysthymic Disorder1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.